RESTORIN™ is the first nutraceutical supplement in Seragon’s pipeline
Seragon Pharmaceuticals, Inc., based in the US, has announced the release of RESTORIN™, an advanced daily supplement for healthy aging at Lifestyle Expo Tokyo.
RESTORIN™ is a controlled-release NMN supplement with senolytic enhancement. The novel product utilizes a proprietary form of NMN to boost nicotinamide adenine dinucleotide (NAD+), the central metabolic cofactor in a number of essential biological processes such as mitochondrial respiration and DNA repair.
RESTORIN™ is engineered with SERC™ controlled release technology to achieve targeted enteric delivery and efficient absorption of active ingredients. RESTORIN™’s health benefits are further enhanced with several compounds carrying sirtuin-activating and senolytic properties.
For years, scientists have focused on evaluating the effects of NAD+ and its precursors on the biological process of aging. Building on the scientific breakthroughs from leading research institutions, RESTORIN™ is a proprietary form of oral NMN supplementation designed to optimize cellular metabolism and promote healthy aging.
RESTORIN™ is the first nutraceutical supplement in Seragon’s pipeline, joining a family of innovative products and services that continue to expand the company’s contribution to better human health.
